|
Bio-Rad Laboratories Incorporated, founded in 1952, provides 70,000 clients worldwide with clinical diagnostics and life science research tools and services. The firm serves commercial and academic organizations across the Americas, Europe, Asia, and Africa. The company's technology and services support genomics, proteomics, biopharmaceutical discovery, and food safety research and development operations. The firm's products are built on electrophoresis, imaging, immunoassay, chromatography, and other technologies. Bio-Rad Laboratories competitors include Amersham, Applied Biosystems, Invitrogen, Affymetrix, Roche, and Johnson & Johnson. Bio-Rad Laboratories went public in 1966. It is listed on the American Stock Exchange under the BIO and BIO.B symbols. Bio-Rad Laboratories was founded by David and Alice Schwartz.
|